Eagle Pharmaceuticals has acquired 3 companies, including 2 in the last 5 years.
Eagle Pharmaceuticals’ largest acquisition to date was in 2022, when it acquired Acacia Pharma for $95M. Eagle Pharmaceuticals has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).
50 Tice Boulevard Suite 315,
Woodcliff Lake, New Jersey
07677
United States,
(201) 326-5300
www.eagleus.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2022-08-09 |
Enalare Therapeutics · Life Science
Princeton, New Jersey · www.enalare.com Enalare Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including community drug overdose, postoperative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, New Jersey. |
- | Stake Purchase | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
